Fake Blood Unit Sold To Patient For Rs 7,000 At UP Medical College, FIR Registered

Hardoi:  A shocking case of illegal blood trade has come to light at the Hardoi Medical College in Uttar Pradesh, raising serious concerns about patient safety and the integrity of healthcare systems. A patient in dire need of a blood transfusion was allegedly sold fake blood for Rs 7,000, putting his life at risk.

Krishna Murari, admitted to the hospital for treatment, required an urgent blood transfusion. His relative, Kaushal Kishore Mishra, desperately searched for a donor and found an individual who offered to provide a unit of blood for an exorbitant price of Rs 7,000.

The following morning, when the family requested the blood for the transfusion, a routine check by the blood bank staff revealed a shocking truth. Not only was the attached slip fake, but the blood itself was found to be severely deficient in hemoglobin, rendering it unfit for transfusion. The timely intervention of the blood bank staff ensured that the patient received a safe unit of blood from the hospital’s reserves.

Dr. Pawan Kumar, in charge of the blood bank stated that the investigation revealed tampering and manipulation of the blood unit. Dr. JK Verma, the Chief Medical Superintendent of the hospital, assured swift action against the perpetrators. An FIR has been registered, and a thorough investigation is underway to expose the network involved in this dangerous racket, he said.

When Madhur reached the blood bank in the morning to get blood, Aqeel Khan, who was on duty, compared the papers and the blood bottle. The papers were found to be fake, while the blood bottle also had a sticker of the medical college. Aqeel Khan informed the DIO about this matter . CMS Dr. JK Verma said that this blood does not seem to be of good quality , so it will be sent for testing. At present, another blood has been made available to the patient free of cost. The CMS said that this entire matter will be investigated.

Related Posts

Cancer cure must not be hostage to Big Pharma

In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients